TY  - JOUR
A1  - Fulda, Simone
T1  - Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link
T2  - Oncotarget
N2  - The proteasome inhibitor Bortezomib has been identified as a potent enhancer of TRAIL-induced apoptosis in several human cancers. However, the identification of the underlying molecular mechanisms of this synergistic cell death induction has been ongoing over the last years. A recent study identifies a new mechanism of action for the synergism of TRAIL and Bortezomib.
KW  - cancer
KW  - apoptosis
KW  - chemotherapy
KW  - proteasome inhibitor
KW  - TRAIL
Y1  - 2011
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/22359
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30-102383
UR  - http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=277&path[]=421
SN  - 1949-2553
N1  - Copyright: © Fulda. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
VL  - 2
IS  - 5
SP  - 418
EP  - 421
PB  - Impact Journals LLC
CY  - [S.l.]
ER  -